BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30693699)

  • 1. [Roles of CCAAT enhancer binding protein α in acute myeloblastic leukemia].
    Shi T; Ye X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 May; 47(5):552-557. PubMed ID: 30693699
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Liu M; Du M; Yu J; Qian Z; Gao Y; Pan W; Zhao X; Wang M; Li H; Zheng J; Huang Q; Wang LM; Xiao H
    Oncoimmunology; 2022; 11(1):2016158. PubMed ID: 35003895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP-IGH fusion gene.
    Odaira K; Yasuda T; Okada K; Shimooka T; Kojima Y; Noura M; Tamura S; Kurahashi S; Iwamoto E; Sanada M; Matsumura I; Miyazaki Y; Kojima T; Kiyoi H; Tsuzuki S; Hayakawa F
    Cancer Sci; 2023 Mar; 114(3):781-792. PubMed ID: 36341510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homodimer-mediated phosphorylation of C/EBPα-p42 S16 modulates acute myeloid leukaemia differentiation through liquid-liquid phase separation.
    Wang D; Sun T; Xia Y; Zhao Z; Sheng X; Li S; Ma Y; Li M; Su X; Zhang F; Li P; Ma D; Ye J; Lu F; Ji C
    Nat Commun; 2023 Oct; 14(1):6907. PubMed ID: 37903757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of gene targets of mutant C/EBPα reveals a critical role for MSI2 in CEBPA-mutated AML.
    Heyes E; Schmidt L; Manhart G; Eder T; Proietti L; Grebien F
    Leukemia; 2021 Sep; 35(9):2526-2538. PubMed ID: 33623142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor C/EBPα-induced microRNA-30c inactivates Notch1 during granulopoiesis and is downregulated in acute myeloid leukemia.
    Katzerke C; Madan V; Gerloff D; Bräuer-Hartmann D; Hartmann JU; Wurm AA; Müller-Tidow C; Schnittger S; Tenen DG; Niederwieser D; Behre G
    Blood; 2013 Oct; 122(14):2433-42. PubMed ID: 23974200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gain-of-Function Effects of N-Terminal CEBPA Mutations in Acute Myeloid Leukemia.
    Schmidt L; Heyes E; Grebien F
    Bioessays; 2020 Feb; 42(2):e1900178. PubMed ID: 31867767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic modification of CCAAT/enhancer binding protein alpha expression in acute myeloid leukemia.
    Hackanson B; Bennett KL; Brena RM; Jiang J; Claus R; Chen SS; Blagitko-Dorfs N; Maharry K; Whitman SP; Schmittgen TD; Lübbert M; Marcucci G; Bloomfield CD; Plass C
    Cancer Res; 2008 May; 68(9):3142-51. PubMed ID: 18451139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia.
    Hughes JM; Legnini I; Salvatori B; Masciarelli S; Marchioni M; Fazi F; Morlando M; Bozzoni I; Fatica A
    Oncotarget; 2015 Jul; 6(21):18534-44. PubMed ID: 26053097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restoration of CCAAT enhancer binding protein α P42 induces myeloid differentiation and overcomes all-trans retinoic acid resistance in human acute promyelocytic leukemia NB4-R1 cells.
    Wang L; Xiao H; Zhang X; Liao W; Fu S; Huang H
    Int J Oncol; 2015 Nov; 47(5):1685-95. PubMed ID: 26397153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEBPA-mutated leukemia is sensitive to genetic and pharmacological targeting of the MLL1 complex.
    Schmidt L; Heyes E; Scheiblecker L; Eder T; Volpe G; Frampton J; Nerlov C; Valent P; Grembecka J; Grebien F
    Leukemia; 2019 Jul; 33(7):1608-1619. PubMed ID: 30679799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha.
    Koschmieder S; D'Alò F; Radomska H; Schöneich C; Chang JS; Konopleva M; Kobayashi S; Levantini E; Suh N; Di Ruscio A; Voso MT; Watt JC; Santhanam R; Sargin B; Kantarjian H; Andreeff M; Sporn MB; Perrotti D; Berdel WE; Müller-Tidow C; Serve H; Tenen DG
    Blood; 2007 Nov; 110(10):3695-705. PubMed ID: 17671235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C/EBPalpha in leukemogenesis: identity and origin of the leukemia-initiating cell.
    Schuster MB; Porse BT
    Biofactors; 2009; 35(3):227-31. PubMed ID: 19322763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm.
    Togami K; Kitaura J; Uchida T; Inoue D; Nishimura K; Kawabata KC; Nagase R; Horikawa S; Izawa K; Fukuyama T; Nakahara F; Oki T; Harada Y; Harada H; Aburatani H; Kitamura T
    Exp Hematol; 2015 Apr; 43(4):300-8.e1. PubMed ID: 25534203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells.
    Kirstetter P; Schuster MB; Bereshchenko O; Moore S; Dvinge H; Kurz E; Theilgaard-Mönch K; Månsson R; Pedersen TA; Pabst T; Schrock E; Porse BT; Jacobsen SE; Bertone P; Tenen DG; Nerlov C
    Cancer Cell; 2008 Apr; 13(4):299-310. PubMed ID: 18394553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C/EBPα dysregulation in AML and ALL.
    Paz-Priel I; Friedman A
    Crit Rev Oncog; 2011; 16(1-2):93-102. PubMed ID: 22150310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of the acute myeloid leukemia cell line Kasumi-6 from a patient with a dominant-negative mutation in the DNA-binding region of the C/EBPalpha gene.
    Asou H; Gombart AF; Takeuchi S; Tanaka H; Tanioka M; Matsui H; Kimura A; Inaba T; Koeffler HP
    Genes Chromosomes Cancer; 2003 Feb; 36(2):167-74. PubMed ID: 12508245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presence of C/EBPα and its degradation are both required for TRIB2-mediated leukaemia.
    O'Connor C; Lohan F; Campos J; Ohlsson E; Salomè M; Forde C; Artschwager R; Liskamp RM; Cahill MR; Kiely PA; Porse B; Keeshan K
    Oncogene; 2016 Oct; 35(40):5272-5281. PubMed ID: 26996668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the C/EBPα signaling pathway in acute myeloid leukemia (Review).
    Song G; Wang L; Bi K; Jiang G
    Oncol Rep; 2015 May; 33(5):2099-106. PubMed ID: 25760953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C/EBPα deregulation as a paradigm for leukemogenesis.
    Pulikkan JA; Tenen DG; Behre G
    Leukemia; 2017 Nov; 31(11):2279-2285. PubMed ID: 28720765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.